Course Overview
Duration:
This course should take 30-45 minutes to complete
Certification:
A certificate is issued once a minimum of 80% is achieved in the final quiz section.
Summary:
This course is intended to benefit regulatory good clinical practice (GCP) inspectors and sponsor auditors who audit clinical trials in particular:
- Regulatory authorities or sponsors in the process of building up their GCP inspection/audit team and an inspection/audit programme
- Regulatory authorities or sponsors which require further, up to date training in the planning, conduct and reporting of GCP inspections/audits for their inspection/audit team.
Objectives:
Upon completion of this course, you will have an understanding of:
- The procedures involved in planning, conducting and reporting inspections/audits, specifically at clinical investigator sites.
- Some of the general principles described could also be used when conducting inspections at other sites e.g. those of the sponsors and contract research organisations (CRO).
Prerequisite:
It is recommended that before commencing this course, participants may find it valuable to complete the course ‘ ICH Good Clinical Practice’ available on the Global Health Training Centre website (https://globalhealthtrainingcentre.tghn.org/elearning/)
There is the possibility for this course to be offered as a face to face training course in conjunction with an onsite national inspection at a clinical investigator site. This would provide the opportunity to gain hands-on experience in the conduct of an inspection by implementing the theoretical aspects of the course, into real life practice. For further information and details please contact training@theglobalhealthnetwork.org
Acknowledgements
The Global Health Training Centre is built through the support and partnership of the Bill and Melinda Gates Foundation, the World-Wide Antimalarial Resistance Network and the East African Consortium for Clinical Research.
Author:
- Thania Spathopoulou - National Organisation for Medicines, Greece. GCP Inspector seconded to the European Medicines Agency:
‘I would like to express my thanks to the National Organisation for Medicines, Greece and the European Medicines Agency for giving me the permission to design this course’
Editor:
- Susan Bull - Head, GlobalHealthReviewers.org , and Senior Researcher, The Ethox Centre, Nuffield Department of Population Health, University of Oxford
Reviewers:
- Lisbeth Bregnhøj - Medicines Inspector, Danish Health and Medicines Authority
- Gunnar Danielsson - Senior Expert, Pharmaceutical Inspector, Inspection Unit, Medical Products Agency, Sweden
- Mimi Darko - Safety Monitoring & Clinical Trials Division, Food and Drugs Authority, Ghana
- Barbara Malungu – Country Head/Director of PHACT-Uganda (Public Health Alliance for Clinical Trials) and Founder and President of TransContinental-QA (TCQA)
- Ria Christine Siagian - Clinical Trial Section, The National Agency of Drug and Food Control, Indonesia
Your feedback is greatly appreciated; please take a couple of minutes to tell us your thoughts on this course: